Կիպրոս - հունարեն - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - dorzolamide hydrochloride - eye drops, solution - 20mg/ml - dorzolamide hydrochloride (8000002380) 22,26mg - dorzolamide

Եվրոպական Միություն - հունարեն - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - Νεοπλάσματα του μαστού - Αντινεοπλασματικοί παράγοντες - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Եվրոպական Միություն - հունարեն - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - Αντινεοπλασματικοί παράγοντες - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Եվրոպական Միություն - հունարեն - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - Λέμφωμα, mantle-cell - Αναστολείς πρωτεϊνικής κινάσης - treatment of mantle cell lymphoma (mcl).

Կիպրոս - հունարեն - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - erythromycin ethylsuccinate - powder for oral suspension - 250mg/5ml - erythromycin ethylsuccinate (0001264626) 250mg base - erythromycin

Կիպրոս - հունարեն - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

spyros stavrinides chemicals ltd (0000003131) 28a-b stassinou ave, flat a2, nicosia, 1060, 21278 - sulfadimidine - solution for injection - 308.9 mg/ml - sulfadimidine (0000057681) 308.9mg - sulfonamides for veterinary use only

Կիպրոս - հունարեն - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

phadisco ltd (0000003025) 185 yiannou kranidioti avenue, latsia, 2234 - cefaclor - powder for oral suspension - 250mg/5ml - cefaclor (0053994733) 250mg - cefaclor

Կիպրոս - հունարեն - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

phadisco ltd (0000003025) 185 yiannou kranidioti avenue, latsia, 2234 - cefaclor - powder for oral suspension - 125mg/5ml - cefaclor (0053994733) 125mg - cefaclor

Կիպրոս - հունարեն - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

dr. falk pharma gmbh (0000008100) leinenweberstr. 5, freiburg, d-79108 - ursodeoxycholic acid - oral suspension - 250mg/5ml - ursodeoxycholic acid (0000128132) 250mg - ursodeoxycholic acid

Հունաստան - հունարեն - Εθνικός Οργανισμός Φαρμάκων

ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522 - cycloserine - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 250mg/cap - cycloserine